Table 3.
Outcomes (N = 60).
| Variable | Level | PA (N = 36) | RLR (N = 24) | p-Value 1 |
|---|---|---|---|---|
| In-hospital stay (days), median (min–max) | 2 (1–6) | 4 (1–18) | <0.001 | |
| Max bilirubin (mg/dL), median (min–max) | 1.45 (0.33–9.88) | 1.41 (0.52–9.17) | 0.59 | |
| Max INR, median (min–max) | 1.29 (0.77–1.92) | 1.35 (1.07–2.11) | 0.12 | |
| Max creatinine (mg/dL), median (min–max) | 0.86 (0.59–1.29) | 0.79 (0.52–2.32) | 0.37 | |
| Morbidity, N (%) 2 3 | Clavien 0 | 29 (81) | 15 (63) | 0.15 |
| Clavien > 0 | 7 (19) | 9 (38) | ||
| Clavien 0 | 29 (81) | 15 (63) | 0.34 | |
| Clavien I–II | 6 (17) | 8 (33) | ||
| Clavien III–IV | 1 (3) | 1 (4) | ||
| Liver failure, N (%) | No | 36 (100) | 23 (96) | 0.40 |
| Yes | 0 (0) | 1 (4) | ||
| Readmission within 30 days, N (%) | No | 34 (94) | 23 (96) | 1.00 |
| Yes | 2 (6) | 1 (4) |
PA: percutaneous ablation and RLR: robotic liver resection. 1 Wilcoxon signed rank test for continuous variables and Fisher’s exact test for categorical variables. 2 Clavien I and II: 6 in PA (1 patient with gastroparesis, vomit, and naso-gastric tube (NGT) placement; 3 patients with fever; 1 patient with hematoma and fever, and 1 patient with fever and high transaminase levels) and 8 in RLR (3 patients with ascites, 1 patient with pneumothorax, 2 patients with fever, 1 patient with grade B post-hepatectomy liver failure, and 1 patient with pneumonia). Clavien III and IV: 1 in PA (post-procedure subcapsular hematoma and laceration that required arterial embolization and transfusion) and 1 in RLR (abdominal abscess). 3 P-value of the Fisher’s exact test in Clavien I and II vs. Clavien 0: 0.21. P-value of the Fisher’s exact test in Clavien III and IV vs. Clavien 0: 1.00. Note: both patients with Clavien III and IV had an ALBI score = 1. In a logistic model with the event “Clavien > 0” and “Procedure” (PA vs. RLR) and “ALBI score” as covariates, the p-value of the procedure was 0.084.